1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Global Liquid Biopsy Market, Analysis and Forecast, 2017-2025

Global Liquid Biopsy Market, Analysis and Forecast, 2017-2025

  • November 2017
  • 314 pages
  • ID: 5228682
  • Format: PDF
  • By BIS Research

Summary

Table of Contents

A biopsy is the most common, definitive medical procedure used for cancer diagnosis and treatment monitoring. Tissue biopsy, is widely adopted procedure to diagnose cancer. However, a major drawback for tissue based diagnosis approach is its dependency on invasive surgical procedures which in many instances preclude the regular treatment monitoring and sometimes the initial diagnosis too.

The search for better minimal invasive diagnostic procedures to aid regular monitoring of the patient’s response towards the treatment gave birth to liquid biopsy tests. In the recent years, the impressive research on cancer biomarkers’ presence in biological fluids, such as blood, which can be collected through minimal invasive techniques has yielded promising results to develop better minimal invasive diagnostics procedures known as liquid biopsies.

Liquid biopsy is a minimal invasive medical procedure with the ability to detect the presence of molecular cancer biomarkers in the biological fluids. The derived test results help the doctors in deciding the further steps in the treatment of the patient suffering from cancer. The test principally involves the usage of samples of biological fluids, such as blood, urine, serum, and saliva, among others, and then the enrichment of the samples using different techniques, such as Next generation Sequencing (NGS), and Polymerase Chain Reaction (PCR), to detect the mutations known to cause cancer.

The liquid biopsy market is expected to grow at a near double digit annual growth rate. The abilities of liquid biopsy, such as minimal invasiveness, possibility of continuous monitoring of the patient’s response towards treatment, and the monitoring of clonal mutations, combined with the growing prominence for precision medicine have fueled the growth of the liquid biopsy market.

The research study comprises in-depth analysis of the market trends and market size through different approaches. The entire market has been segmented and estimated in five different approaches, namely “by product & services”, “by biomarker and technology”, “by cancer type”, “by end users”, and “by geography”.

In terms of “by products & services”, the market has been segmented into kits & reagents, platforms & instruments, and services. In terms of “by biomarker and technology” the market has been segmented into circulating tumor cell (CTC), circulating tumor DNA (ctDNA), and extracellular vesicles (EV). In terms of “by cancer type” the market has been segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, and liver cancer. In terms of “by end users” the market has been tracked through hospital & laboratory, government & academic research centers. And in terms of “by geography” the market has been segmented into North America, Europe, Asia Pacific, and LAMEA.

Some of the key players who have been contributing significantly to the liquid biopsy market are Janssen Diagnostics, LLC; Biocept Inc., Bio-Rad Laboratories Inc., Guardant Health, Inc., Myriad Genetics, QIAGEN, RainDance Technologies, Roche AG, Trovagene Inc., Adaptive Biotechnologies, Natera, Inc., Cynvenio Biosystems, Inc., Epic Sciences, ANGLE plc, Illumina, Inc., Menarini Silicon Biosystems., MDxHealth, Sysmex Inostics GmbH, Genomic Health, and NeoGenomics Laboratories, Inc.

The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into the consideration before entering into the global liquid biopsy market.

The answers to the following key questions can be derived from this report:
• What are the major market drivers, challenges, and opportunities in the global liquid biopsy market?
• How did the liquid biopsy market evolve and what is its scope in the future?
• What are the key developmental strategies which are being implemented by the key players to stand out in this market?
• What is the total addressable market (TAM), segmental addressable market (SAM) and the potential market opportunity of the global liquid biopsy market?
• What is the market share of the leading segments and sub-segments of the liquid biopsy market in 2016 and 2025?
• How will each segment of the global liquid biopsy market grow during the forecast period and what will be their revenue generation at the end of 2025?
• Who are the key players dominating the global liquid biopsy market and their respective share?
• What are the influencing factors that may affect the market share of the key players?
• How will the industry evolve during the forecast period 2016-2025?
• Which product type is dominating the market?
• What are the dominating products offered by different companies for each product type, available in the market?
• How the market is distributed on the basis of application?
• Which cancer type is the leading contributor to the global liquid biopsy market revenue?
• Which geographical location will contribute to the highest sales of the liquid biopsy products?

This research report aims at answering various aspects of the global liquid biopsy market with the help of key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global liquid biopsy market and assesses the factors governing the same.

Executive Summary
A biopsy is the most common, definitive medical procedure used for cancer diagnosis and treatment monitoring. Tissue biopsy is the most widely adopted procedure to diagnose cancer. However, a major drawback of the tissue based diagnosis approach is its dependency on invasive surgical procedures which in many instances preclude the regular treatment monitoring and sometimes the initial diagnosis too.

The search for better minimally invasive diagnostic procedures to aid the regular monitoring of the patient’s response towards the treatment, have paved pathway for the most awaited change in diagnostic procedures. In the recent years, the impressive research on cancer biomarkers’ presence in biological fluids, such as blood, which can be collected through minimally invasive techniques has opened up new hopes to develop promising minimally invasive diagnostic procedures. These procedures developed based on the detection of biomarkers in biological fluids which were later named as Liquid biopsy.

Liquid biopsy is a non-invasive medical procedure which has the ability to detect the presence of molecular cancer biomarkers in biological fluids. The derived test results help the doctors in deciding the further steps in the treatment of the cancer patients.

The purpose of the study is to gain a holistic view of the liquid biopsy market in terms of various factors influencing it, such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centered upon conducting a detailed study of the solutions allied with the liquid biopsy market. The global liquid biopsy market has been segmented into five different parts, namely by product, by type of biomarker and technology, by application, by end user, and by geography. These segments have been further segmented into many sub segments to ease the market estimation and to gain a holistic view of the market.

The global liquid biopsy market is anticipated to grow over $4,434 million by 2025. With the growing prominence for non-invasive diagnostic procedures, the global liquid biopsy market is expected to register an impressive double digit growth rate in the forecast period 2016-2025. The global liquid biopsy market, by product, is being dominated by Kits & Consumables, the sub segment was reported to contribute approximately 63% to the global liquid biopsy market value in 2016. The sub segment is expected to maintain its dominating share and is estimated to contribute approximately 61% to the global liquid biopsy market value in 2025.

On the other hand, the global liquid biopsy market, by type of biomarker, is being dominated by Circulating Tumor Cells (CTCs), the sub segment was reported to contribute 56% to the global liquid biopsy market value in 2016. The sub segment is expected to maintain its dominating market share and is estimated to contribute approximately 45% to the global liquid biopsy market value in 2025.

Additionally, the global liquid biopsy market, by application, is being dominated by Oncology Application. The sub segment was estimated to contribute 97% to the global liquid biopsy market value in 2016. The sub segment is expected to maintain its leading share and is estimated to contribute approximately 92% to the global liquid biopsy market value in 2025. The North America liquid biopsy market held the largest market share in 2016. The Asia Pacific liquid biopsy market is expected to register the highest CAGR of 26.3% in the forecast period 2016-2025.

The key players of the market include Adaptive Biotechnologies, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Cynvenio Biosystems, Inc., Epic Sciences, F. Hoffmann-La Roche AG, Genomic Health, Guardant Health, Inc., Illumina, Inc., Janssen Diagnostics, LLC, MDxHealth, Menarini Silicon Biosystems., Myriad Genetics, Natera, Inc., NeoGenomics Laboratories, Inc., QIAGEN, RainDance Technologies, Inc., Sysmex Inostics GmbH, Thermo Fisher Scientific, and Trovagene Inc.

Currently, a significant work is being carried out to develop medical procedure based on liquid biopsy, for diagnosis of several diseases other than cancer. Through the detection of different biomarkers, the diagnosis of cardiovascular diseases, infections, immunological and genetic disorders is certainly possible and opens new hopes for the patients. The development of test kits to diagnose the above mentioned diseases appears to be a great opportunity to serve the market, for both the new and the existing players.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Row

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($4599)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • December 2019

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019" provides an ...

Asia Pacific Prenatal & Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Product, Disease Indication, Technology, End User and Geography

Asia Pacific Prenatal & Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Product, Disease Indication, Technology, End User and Geography

  • $ 3000
  • November 2019

The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 1,679.956 Mn in 2027 from US$ 630.914 in 2018. The market is estimated to grow with a CAGR of 11.6% from 2019-2027.The ...

GLOBAL LIQUID BIOPSY MARKET FORECAST 2019-2027

GLOBAL LIQUID BIOPSY MARKET FORECAST 2019-2027

  • $ 2500
  • September 2019

KEY FINDINGSDevelopments in precision medicines, increasing prevalence of cancer cases in the elderly population, and supportive government initiatives are some of the factors that are contributing to ...


ref:plp2017

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on